Document:

Exhibit 10.18

 

Rotech Healthcare Holdings Inc.

Employee Stock Purchase Plan

 

1.            Purpose.
The purpose of this Employee Stock Purchase Plan (the “Plan”) of Rotech Healthcare Holdings Inc., a Delaware corporation
(the “Company”), is to provide eligible Employees of the Company and its Designated Subsidiaries with a convenient
opportunity to purchase Common Stock of the Company. It is the intention of the Company to have the Plan qualify as an “Employee
Stock Purchase Plan” under Section 423 of the Code. The provisions of the Plan shall, accordingly, be construed so as to extend
and limit participation in a manner consistent with the requirements of that section of the Code.

 

2.            Definitions.
The following definitions shall apply throughout the Plan.

 

(a)           “Board”
means the Board of Directors of the Company.

 

(b)           “Code”
means the United States Internal Revenue Code of 1986, as amended, and any successor thereto. References to any section of the Code shall
be deemed to include any regulations or other interpretative guidance under such section, and any amendments or successors thereto.

 

(c)           “Committee”
means a committee appointed by the Board. In the absence of a contrary designation by the Board, the Compensation Committee of the Board
shall be the Committee hereunder.

 

(d)           “Common
Stock” means the common stock of the Company, par value $0.001 per share (and any stock or other securities into which such
common stock may be converted or into which it may be exchanged).

 

(e)           “Company”
has the meaning set forth in Section 1.

 

(f)            “Compensation”
means the base pay (determined on such date as may be established by the Committee) received by an Employee from the Company or a Designated
Subsidiary. Base pay shall (i) be determined prior to any salary reduction contributions under a cafeteria plan pursuant to Section 125
of the Code, any salary reduction amounts pursuant to a qualified transportation benefit program pursuant to Section 132(f) of
the Code, and any elective deferrals to a nonqualified deferred compensation plan and to a cash or deferred plan pursuant to Section 401(k) of
the Code and (ii) exclude any imputed income arising under any group insurance or benefit program, travel expenses, business and
relocation expense, and income received in connection with stock options or other equity-based awards.

 

(g)           “Continuous
Status as an Employee” means the absence of any interruption or termination of service as an Employee. Continuous Status as
an Employee shall not be considered interrupted in the case of (i) sick leave, military leave, or other bona fide leave of absence
that is required by law to be considered uninterrupted service or that is otherwise approved by the Committee if the period of such leave
does not exceed 90 days, or if longer, so long as the individual’s right to reemployment as an Employee is guaranteed either by
contract or statute; or (ii) transfers between locations of the Company or between and among the Company and its Designated Subsidiaries.
For purposes of clarification, the disposition of a Designated Subsidiary shall constitute a termination of the Continuous Status as an
Employee of any Employee employed by such Designated Subsidiary.

 

    

     

    

 

(h)           “Contributions”
means all amounts credited to the notional account of a Participant pursuant to the Plan.

 

(i)            “Corporate
Transaction” means a sale of all or substantially all of the Company’s assets, or a merger, consolidation, or other capital
reorganization of the Company with or into another corporation, or any other transaction or series of related transactions in which the
Company’s stockholders immediately prior thereto own less than 50% of the voting stock of the Company (or its successor or ultimate
parent company) immediately thereafter, but excluding any acquisition of voting stock by the Company or any of its affiliates or by any
employee benefit plan sponsored or maintained by the Company or any of its affiliates.

 

(j)            “Designated
Subsidiaries” means all Subsidiaries, except with respect to any of such Subsidiaries that the Committee has determined is not
eligible to participate in the Plan.

 

(k)           “Employee”
means any person who (i) has had Continuous Status as an Employee of the Company or one of its Designated Subsidiaries for a period
of at least sixty (60) days, (ii) is customarily employed thereby for at least 20 hours per week and more than five (5) months
in a calendar year, and (iii) is classified as an employee for tax purposes.

 

(l)            “Exchange
Act” means the United States Securities Exchange Act of 1934, as amended, and any successor thereto. References to any section
of (or rule promulgated under) the Exchange Act shall be deemed to include any rules, regulations or other interpretative guidance
under such section or rule, and any amendments or successors thereto.

 

(m)          “Fair
Market Value” means, for any date, with respect to a Share, the closing sales price of a Share on the primary exchange on which
the Common Stock is traded on such date or, in the event that the Common Stock is not traded on such date, then the immediately preceding
trading date. In the absence of an established market for Common Stock, the Fair Market Value of a Share shall be determined in good faith
by the Committee and such determination shall be conclusive and binding on all persons. The “Fair Market Value” of
all other property shall be determined in good faith by the Committee, and such determination shall be conclusive and binding on all persons.

 

(n)           “Indemnifiable
Person” shall have the meaning ascribed to it in Section 27.

 

    2

     

    

 

(o)           “Maximum
Number of Shares” means, with respect to a given Offering Period, a number of Shares equal to the quotient of (x) $25,000
divided by (y) the Fair Market Value of a Share on the Offering Date, which Maximum Number of Shares may be pro-rated by the Committee
for an Offering Period that is less than one (1) year in duration.

 

(p)           “New
Purchase Date” shall have the meaning ascribed to it in Section 16(b).

 

(q)           “Offering
Date” means the first day of each Offering Period, as determined in accordance with Section 3.

 

(r)            “Offering
Period” means a period described in Section 3.

 

(s)           “Plan”
has the meaning set forth in Section 1.

 

(t)            “Plan
Administrator” means the Committee, or such other institution selected by the Committee.

 

(u)           “Participant”
means an eligible Employee who has elected to participate in the Plan in accordance with Section 5.

 

(v)           “Purchase
Date” means, unless otherwise determined by the Committee, December 31 of each calendar year or, in the event that the
Common Stock is not traded on such date, the immediately preceding trading date, as applicable.

 

(w)          “Purchase
Price” means, with respect to a given Offering Period, an amount equal to 85% (or such greater percentage as designed by the
Committee) of the Fair Market Value of a Share on (i) the Purchase Date or (ii) the Offering Date, whichever amount is lower;
provided, that the Purchase Price will in no event be less than the par value of a Share.

 

(x)           “Reserves”
shall have the meaning ascribed to it in Section 16(a).

 

(y)          “Rule 16b-3”
means Rule 16b-3 adopted under Section 16 of the Exchange Act.

 

(z)           “Securities
Act” means the United States Securities Act of 1933, as amended, and any successor thereto. References to any section of (or
rule promulgated under) the Securities Act shall be deemed to include any rules, regulations or other interpretative guidance under
such section or rule, and any amendments or successors thereto.

 

(aa)        “Share”
means a share of Common Stock, as adjusted in accordance with Section 16.

 

(bb)       “Subsidiary”
means a corporation which is a “subsidiary corporation” of the Company within the meaning of Section 424(f) of the
Code.

 

    3

     

    

 

3.         Offering
Periods. The Plan shall be implemented by a series of consecutive Offering Periods commencing
on January 1 and ending on December 31 of each calendar year, subject to commencement of the initial Offering Period, if any,
on such date and for such duration, if any, as determined by the Committee in its sole discretion. The Committee shall have the authority
to change the duration (subject to a maximum Offering Period of 27 months), frequency, start date, and end dates of any Offering Periods.

 

4.         Eligibility.
Subject to the requirements of Section 5 and the limitations imposed by Section 423(b) of the Code (and unless different
dates are established by the Committee in respect of any Offering Period), a person shall be eligible to participate in an Offering Period
if such person is an Employee as of the date on which an election for participation in the Offering is required pursuant to Section 5(b) below;
provided, however, that the Committee may provide that an Employee shall not be eligible to participate in an Offering Period
if: (i) such Employee is a highly compensated employee within the meaning of Section 423(b)(4)(D) of the Code; (ii) such
Employee has not met a service requirement designated by the Committee pursuant to Section 423(b)(4) (A) of the Code (which
service requirement may not exceed two years); and/or (iii) such Employee is a citizen or resident of a foreign jurisdiction and
the grant of a right to purchase Common Stock under the Plan to such Employee would be prohibited under the laws of such foreign jurisdiction
or the grant of a right to purchase Common Stock under the Plan to such Employee in compliance with the laws of such foreign jurisdiction
would cause the Plan to violate the requirements of Section 423 of the Code, as determined by the Committee in its sole discretion;
provided, further, that any exclusion in clause (i), (ii) or (iii) shall be applied in an identical manner under
each Offering Period to all Employees, in accordance with Treasury Regulation Section 1.423-2(e).

 

5.         Participation.

 

(a)        Participation
in the Plan is completely voluntary. Except as set forth in Section 7(b) below, participation in one or more of the offerings
under the Plan shall neither limit, nor require, participation in any other offering.

 

(b)        An
eligible Employee may become a Participant in respect of an Offering Period by electing to participate in the manner approved by the Committee.
An Employee who elects to participate in an Offering Period shall do so at least ten (10) days prior to the Offering Date, unless
a different time for electing to participate (including following the Offering Date) is set by the Committee.

 

(c)        A
Participant’s election shall indicate either a fixed dollar amount or a percentage of such Participant’s Compensation, in
either case, as may be determined by the Committee, to be contributed during the applicable Offering Period; provided, however,
that a Participant’s election shall be subject to the limitations of Section 7(b).

 

(d)        The
deduction rate selected by a Participation shall remain in effect for subsequent Offering Periods unless the Participant (i) submits
a new election in the manner approved by the Committee, (ii) withdraws from the Plan, or (iii) terminates employment or otherwise
becomes ineligible to participate in the Plan.

 

    4

     

    

 

6.          Method
of Payment of Contributions.

 

(a)         Payroll
deductions shall be made from a Participant’s Compensation during an Offering Period in an aggregate amount equal to the Participant’s
contribution election for such Offering Period. All payroll deductions made by a Participant shall be credited to his or her notional
account under the Plan. Participant may not make a prepayment or any additional payments into such notional account. Payroll deductions
in respect of any Offering Period shall commence on the Offering Date and shall end on the final day of the final payroll period ending
on or prior to the applicable Purchase Date, unless sooner terminated by the Participant as provided in Section 10.

 

(b)         Participants
on an authorized leave of absence during an Offering Period may continue to participate in such Offering Period; provided, however,
that a Participant on an authorized leave of absence will have contributions suspended during such leave of absence and, absent any other
instruction from such Participant, such contributions will resume upon the next payroll following such Participant’s return from
such leave of absence.

 

(c)         Notwithstanding
the foregoing, to the extent necessary to comply with Section 423(b)(8) of the Code and Section 7(b) herein, a Participant’s
payroll deductions may be decreased by the Company to zero during any Offering Period.

 

7.          Grant
of Option.

 

(a)         On
each Offering Date, each Participant shall be deemed to have been granted an option to purchase as many Shares (rounded down to the nearest
whole Share) as may be purchased with his or her Contributions during the related Offering Period at the Purchase Price; provided,
however, that such option shall be subject to the limitations set forth in Section 7(b) below and Section 11, and
may be reduced pursuant to Section 6, in each case, if applicable.

 

(b)         Notwithstanding
any contrary provisions of the Plan, each option to purchase Shares under the Plan shall be limited as necessary to prevent any Employee
from (i) immediately after the grant, owning capital stock of the Company and holding outstanding options to purchase capital stock
of the Company possessing, in the aggregate, more than 5% of the total combined voting power or value of all classes of stock of the Company
or of any Subsidiary, including for this purpose any stock attributed to such Employee pursuant to Section 424(d) of the Code,
(ii) acquiring rights to purchase stock under all employee stock purchase plans (as described in Section 423 of the Code or
any other similar arrangements maintained by the Company or any of its Subsidiaries) of the Company and its Subsidiaries which accrue
at a rate that exceeds $25,000 of the Fair Market Value of such stock (determined at the time such option is granted) for each calendar
year in which such option is outstanding and exercisable at any time, or (iii) purchasing, in respect of any Offering Period, more
than the Maximum Number of Shares.

 

    5

     

    

 

8.          Exercise
of Option; Interest.

 

(a)         Unless
a Participant withdraws from the Plan as provided in Section 10, his or her option for the purchase of Shares will be exercised automatically
on the applicable Purchase Date, and the number of full Shares subject to the option will be purchased at the applicable Purchase Price
with the accumulated Contributions in his or her notional account. No fractional Shares shall be issued. Any amounts accumulated in a
Participant’s notional account that are not used to purchase Shares (other than any amount that is not sufficient to purchase a
full Share, which shall be automatically carried forward to the next Offering Period) shall be refunded to the Participant as soon as
practicable following the Purchase Date. Notwithstanding Section 9 below, the Shares purchased upon exercise of an option hereunder
shall be deemed to be transferred to the Participant as of the Purchase Date. During his or her lifetime, a Participant’s option
to purchase Shares hereunder is exercisable only by him or her.

 

(b)         At
the time an option granted under the Plan is exercised, in whole or in part, or at the time some or all of the Common Stock issued to
a Participant under the Plan is disposed of, the Participant must make adequate provisions for any applicable federal, state, or other
tax withholding obligations, if any, that arise upon the Purchase Date or the disposition of the Common Stock. At any time, the Company
or a Designated Subsidiary may, but will not be obligated to, withhold from the Participant’s compensation the amount necessary
to meet applicable withholding obligations, including any withholding required to make available to the Company any tax deductions or
benefits attributable to the sale or disposition of Common Stock by the Participant earlier than as described in Section 423(a)(1) of
the Code.

 

(c)         No
interest will be paid or allowed on any money paid into the Plan or credited to the notional account of any Participant.

 

9.          Delivery.
As promptly as practicable after each Purchase Date, the number of Shares purchased by each Participant upon exercise of his or her option
shall be deposited into an account established in the Participant’s name with the Plan Administrator. The Committee may determine
that no Share purchased in respect of an offering may be transferred out of such Participant’s account with the Plan Administrator
other than in connection with a “disposition” (as such term is used in Section 423(a)(1) of the Code) of such Share
for the longer of (x) two (2) years following the Offering Date applicable to such Share and (y) one (1) year following
the Purchase Date applicable to such Share.

 

10.        Voluntary
Withdrawal; Termination of Employment.

 

(a)         A
Participant may withdraw all but not less than all the Contributions credited to his or her notional account under the Plan at any time
prior to the applicable Purchase Date by giving written notice to the Plan Administrator in the manner directed by the Company. All of
the Participant’s Contributions credited to his or her notional account with respect to an Offering Period will be paid to him or
her as soon as administratively practicable after receipt of his or her notice of withdrawal, his or her option for the current Offering
Period will be automatically terminated, and no further Contributions for the purchase of Shares may be made by the Participant with respect
to such Offering Period. A Participant’s withdrawal from the Plan during an Offering Period will not have any effect upon his or
her eligibility to participate in a succeeding Offering Period or in any similar plan that may hereafter be adopted by the Company.

 

    6

     

    

 

(b)          Upon
termination of the Participant’s Continuous Status as an Employee prior to a Purchase Date for any reason, including retirement
or death, the Contributions credited to his or her notional account will be returned to him or her, and his or her option will be automatically
terminated; provided, however, that in the event of the death of a Participant, the Company shall deliver the Contributions
to the executor or administrator of the estate of the Participant or, if no such executor or administrator has been appointed (to the
knowledge of the Company), the Company, in its sole discretion, may deliver such amounts to the spouse or to any one or more dependents
or relatives of the Participant.

 

11.         Shares.

 

(a)          Subject
to adjustment as provided in Section 16, the maximum number of Shares that shall be made available for sale under the Plan shall
be [              ].1 If the Committee determines at any time that, on
a given Purchase Date, the number of Shares with respect to which options are to be exercised may exceed the number of Shares that are
available for sale under the Plan on such Purchase Date, the Company shall make a pro rata allocation of the Shares available for purchase
on such Purchase Date, in as uniform a manner as shall be practicable and as it shall determine to be equitable among all Participants
exercising options to purchase Common Stock on such Purchase Date, and the Committee may, in its sole discretion (x) continue all
Offering Periods then in effect, or (y) terminate any or all Offering Periods then in effect pursuant to Section 17 below.

 

(b)          Shares
to be delivered to a Participant under the Plan will be registered in the name of the Participant.

 

12.         Administration.

 

(a)          Subject
to the express provisions of the Plan, the Committee shall administer the Plan and shall have the sole and plenary power to (i) interpret
and administer, reconcile any inconsistency in, correct any defect in, and supply any omission in the Plan; (ii) establish, amend,
suspend, or waive any rules and regulations and appoint such agents as the Committee shall deem appropriate for the proper administration
of the Plan; and (iii) make any other determination and take any other action that the Committee deems necessary or desirable for
the administration of the Plan, including, without limitation to the foregoing, by changing the duration (subject to a maximum Offering
Period of 27 months), frequency, start date, and end dates of Offering Periods and/or the Purchase Dates. The authority of the Committee
includes, without limitation, the authority to (x) determine procedures for setting or changing payroll deduction percentages, and
obtaining necessary tax withholdings, and (y) adopt amendments to the Plan in accordance with Section 17. All designations,
determinations, interpretations, and other decisions by the Committee (or its delegate) regarding the Plan shall be within the sole discretion
of the Committee, may be made at any time, and shall be final, conclusive, and binding upon all persons or entities, including, without
limitation, the Company, any affiliate, any Participant, any holder or beneficiary of any option, and any shareholder of the Company.
The expenses of administering the Plan shall be borne by the Company.

 

 

1
NTD: Share Pool to equal 2.5% of the fully diluted number of shares of Common Stock outstanding as of the Effective Date.

 

    7

     

    

 

(b)         The
Committee may delegate any or all of its authority and obligations under this Plan to such committee or committees (including without
limitation, a committee of the Board) or officer(s) of the Company as they may designate.

 

(c)         Nothing
in the Plan shall be deemed to authorize the Committee to take any action contrary to applicable law or regulation, or rules of the
NASDAQ or any other securities exchange or inter-dealer quotation service on which the Common Stock is listed or quoted.

 

(d)         Notwithstanding
any delegation of authority hereunder, the Board may itself take any action permitted under the Plan in its sole discretion at any time,
and any reference in this Plan document to the rights and obligations of the Committee shall be construed to apply equally to the Board.
Any references to the Board mean the Board only.

 

13.        Transferability.
Neither amounts accumulated in a Participant’s notional account nor any rights with regard to the exercise of an option or to receive
Shares under the Plan may be assigned, transferred, pledged, or otherwise disposed of in any way (other than by will or by the laws of
descent and distribution, or as provided in Section 10) by the Participant. Any such attempt at assignment, transfer, pledge, or
other disposition shall be without effect, except that the Company may treat such act as an election to withdraw funds in accordance with
Section 10.

 

14.        Use
of Funds. All Contributions received or held by the Company under the Plan may be used by the
Company for any corporate purpose, and the Company shall not be obligated to segregate such Contributions.

 

15.        Reports.
Statements of account will be made available to Participants by the Company or the Plan Administrator in the form and manner designated
by the Committee.

 

    8

     

    

 

16.           Adjustments
Upon Changes in Capitalization; Corporate Transactions.

 

(a)            Subject
to any required action by the stockholders of the Company, (i)  the number of Shares covered by each option under the Plan that has
not yet been exercised, (ii) the number of Shares that have been authorized for issuance under the Plan but that have not yet been
placed under option (collectively, the “Reserves”), (iii) the number of Shares set forth in Section 11 above,
and (iv) the Purchase Price for each then-current Offering Period shall, if applicable, be proportionately adjusted for any increase
or decrease in the number of issued Shares resulting from a stock split, a reverse stock split, a stock dividend, a subdivision, combination,
or reclassification of the Common Stock (including any such change in the number of shares of Common Stock effected in connection with
a change in domicile of the Company), or any other increase or decrease in the number of Shares effected without receipt of consideration
by the Company, or any increase or decrease in the value of a Share resulting from a spinoff or split-up; provided, however,
that conversion of any convertible securities of the Company shall not be deemed to have been “effected without receipt of consideration.”
Such adjustment shall be made by the Committee, whose determination in that respect shall be final, binding, and conclusive. Except as
expressly provided above, no issue by the Company of shares of stock of any class, or securities convertible into shares of stock of any
class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares subject to an option.

 

(b)            In
the event of a dissolution or liquidation of the Company, any Offering Period then in progress will terminate immediately prior to the
consummation of such action, unless otherwise provided by the Committee. In the event of a Corporate Transaction, each option outstanding
under the Plan shall be assumed or an equivalent option shall be substituted by the successor corporation or a parent or subsidiary of
such successor corporation. If the successor corporation (or its parent or subsidiary) refuses to assume or substitute for outstanding
options, each Offering Period then in progress shall be shortened and a new Purchase Date shall be set by the Committee (the “New
Purchase Date”), as of which New Purchase Date any Offering Period then in progress will terminate. The New Purchase Date shall
be on or before the date of consummation of the Corporate Transaction, and the Company shall notify each Participant in writing, at least
ten (10) days prior to the New Purchase Date, that the Purchase Date for his or her option has been changed to the New Purchase Date
and that his or her option will be exercised automatically on the New Purchase Date, unless prior to such date he or she has withdrawn
from the Offering Period as provided in Section 10. For purposes of this Section 16, an option granted under the Plan shall
be deemed to be assumed, without limitation, if at the time of issuance of the stock or other consideration upon a Corporate Transaction,
each holder of an option under the Plan would be entitled to receive upon exercise of the option the same number and kind of Shares or
the same amount of property or cash, or number of securities (or combination thereof) as such holder would have been entitled to receive
upon the occurrence of the transaction if the holder had been, immediately prior to the transaction, the holder of the number of shares
of Common Stock covered by the option at such time (after giving effect to any adjustments in the number of Shares covered by the option
as provided for in this Section 16); provided, however, that if the consideration received in the transaction is not
solely common stock of the successor corporation or its parent (as defined in Section 424(e) of the Code), the Committee may,
with the consent of the successor corporation, provide for the consideration to be received upon exercise of the option to be solely common
stock of the successor corporation or its parent or subsidiary equal in Fair Market Value to the per-Share consideration received by holders
of Common Stock in the transaction.

 

    9

     

    

 

(c)          If
the Company consummates the sale or transfer of a Designated Subsidiary, business unit, or division to an unaffiliated person or entity,
or the spin-off of a Designated Subsidiary, business unit, or division to shareholders during an Offering Period, the Contributions credited
to the notional account of each Participant employed by such Designated Subsidiary, business unit, or division, as applicable, as of the
time of such sale, transfer, or spin-off with respect the offering to which such Offering Period relates will be returned to the Participant
without interest, and the Participant’s option will be automatically terminated.

 

(d)          The
existence of the Plan shall not affect or restrict in any way the right or power of the Company, the Board, the Committee, or the shareholders
of the Company to make or authorize any adjustment, recapitalization, reorganization, or other change in the Company’s capital structure
or its business, any merger or consolidation of the Company, any issue of stock or of options, warrants, or rights to purchase stock or
of bonds, debentures, or preferred or prior-preference stocks whose rights are superior to or affect the Common Shares or the rights thereof
or that are convertible into or exchangeable for Common Shares, or the dissolution or liquidation of the Company or any Affiliate, or
any sale or transfer of all or any part of their assets or business, or any other corporate act or proceeding, whether of a similar character
or otherwise.

 

17.           Amendment
or Termination.

 

(a)            The
Board may amend, alter, suspend, discontinue, or terminate the Plan or any portion thereof at any time; provided, that no such
amendment, alteration, suspension, discontinuation, or termination shall be made without shareholder approval if such approval is necessary
to comply with any tax or regulatory requirement applicable to the Plan (including, without limitation, as necessary to comply with any
applicable rules or requirements of any securities exchange or inter-dealer quotation service on which the Shares may be listed or
quoted); provided, further, that any such amendment, alteration, suspension, discontinuance, or termination that would materially
and adversely affect the rights of any Participant shall not to that extent be effective without the consent of the affected Participant
unless the Committee determines that such amendment, alteration, suspension, discontinuance, or termination is either required or advisable
in order for the Company or the Plan to satisfy any applicable law or regulation.

 

(b)            Except
as provided in Section 16, no such termination of the Plan may affect options previously granted, provided that the Plan or an Offering
Period may be terminated by the Board on a Purchase Date or by the Board’s setting a new Purchase Date with respect to an Offering
Period then in progress if the Board determines that termination of the Plan and/or the Offering Period is in the best interests of the
Company and the stockholders or if continuation of the Plan and/or the Offering Period would cause the Company to incur adverse accounting
charges as a result of a change after the effective date of the Plan in the generally accepted accounting principles applicable to the
Plan.

 

    10

     

    

 

(c)           Without
stockholder consent and without regard to whether any Participant rights may be considered to have been adversely affected, the Committee
shall be entitled to change the Offering Periods, limit the frequency and/or number of changes in the amount withheld that may be made
during an Offering Period, permit payroll withholding in excess of the amount designated by a Participant in order to adjust for delays
or mistakes in the Company’s processing of properly completed withholding elections, establish reasonable waiting and adjustment
periods and/or accounting and crediting procedures to ensure that amounts applied toward the purchase of Common Stock for each Participant
properly correspond with amounts withheld from the Participant’s Compensation, and establish such other limitations or procedures
as the Committee determines in its sole discretion advisable that are consistent with the Plan.

 

18.          No
Rights to Continued Employment. Neither the Plan nor any action taken hereunder shall be construed
as giving any Participant any right to be retained in the employ or service of the Company or an affiliate, or to continue in the employ
or the service of the Company or an affiliate.

 

19.          Beneficiary
Designation. The Participant’s beneficiary shall be the Participant’s spouse (or
domestic partner if such status is recognized by the Company and in such jurisdiction), or if the Participant is otherwise unmarried
at the time of death, the Participant’s estate, except to the extent that a different beneficiary is designated in accordance with
procedures that may be established by the Committee from time to time for such purpose. Notwithstanding the foregoing, in the absence
of a beneficiary validly designated under such Committee-established procedures and/or applicable law who is living (or in existence)
at the time of death of a Participant residing or working outside the United States, any required distribution under the Plan shall be
made to the executor or administrator of the estate of the Participant, or to such other individual as may be prescribed by applicable
law.

 

20.          Equal
Rights and Privileges. Notwithstanding any provision of the Plan to the contrary and in accordance
with Section 423 of the Code, all eligible Employees who are granted options under the Plan shall have the same rights and privileges.

 

21.          No
Rights as a Shareholder. Except as otherwise specifically provided in the Plan, no person shall
be entitled to the privileges of ownership in respect of Shares that are subject to options hereunder until such Shares have been issued
or delivered to that person.

 

22.          Withholding.
To the extent required by applicable federal, state, or local law, a Participant must make arrangements
satisfactory to the Company for the payment of any withholding or similar tax obligations that arise in connection with the Plan.

 

23.          Notices.
All notices or other communications by a Participant to the Company under or in connection with
the Plan shall be deemed to have been duly given when received in the form specified by the Company at the location, or by the person,
designated by the Company for the receipt thereof.

 

    11

     

    

 

24.         Conditions
Upon Issuance of Shares.

 

(a)           The
Plan and the issuance and delivery of Shares under the Plan are subject to compliance with all applicable U.S. federal, state, local,
and non-U.S. laws, rules, and regulations (including but not limited to state, U.S. federal, and non-U.S. securities law, and margin requirements)
and to such approvals by any listing, regulatory, or governmental authority as may, in the opinion of counsel for the Company, be necessary
or advisable in connection therewith. Any securities delivered under the Plan shall be subject to such restrictions, and the person acquiring
such securities shall, if requested by the Company, provide such assurances and representations to the Company as the Company may deem
necessary or desirable to assure compliance with all applicable legal requirements. To the extent permitted by applicable law, the Plan
shall be deemed amended to the extent necessary to conform to such laws, rules, and regulations.

 

(b)           Notwithstanding
any terms or conditions of the Plan to the contrary, the Company shall be under no obligation to offer to sell or to sell, and shall be
prohibited from offering to sell or selling, any Shares pursuant to the Plan unless such Shares have been properly registered for sale
pursuant to the Securities Act with the Securities and Exchange Commission or unless the Company has received an opinion of counsel, satisfactory
to the Company, that such Shares may be offered or sold without such registration pursuant to and in compliance with the terms of an available
exemption. The Company shall be under no obligation to register for sale under the Securities Act any of the Shares to be offered or sold
under the Plan. The Committee shall have the authority to provide that all Shares delivered under the Plan shall be subject to such stop-transfer
orders and other restrictions as the Committee may deem advisable under the Plan, U.S. federal securities laws, or the rules, regulations,
and other requirements of the Securities and Exchange Commission, any securities exchange or inter-dealer quotation service upon which
such Shares are then listed or quoted and any other applicable federal, state, local or non-U.S. laws, rules, regulations, and other requirements,
and the Committee may cause a legend or legends to be put on any such certificates of Common Stock delivered under the Plan to make appropriate
reference to such restrictions or may cause such Common Stock delivered under the Plan in book-entry form to be held subject to the Company’s
instructions or subject to appropriate stop-transfer orders.

 

25.          Term
of Plan; Effective Date. The Plan was adopted by the Board on [       ], 2021, and approved by the
Company’s stockholders [         ], 2021. The Plan shall be effective on [            ], 2021 (the “Effective Date”), and shall
continue in force and effect until terminated under Section 17. Unless sooner terminated by the Board, the Plan shall terminate upon
the ten (10) year anniversary of the Effective Date.

 

26.          Additional
Restrictions of Rule 16b-3. The terms and conditions of options granted hereunder to, and
the purchase of Shares by, persons subject to Section 16 of the Exchange Act shall comply with the applicable provisions of Rule 16b-3.
This Plan shall be deemed to contain, and such options shall contain, and the Shares issued upon exercise thereof shall be subject to,
such additional conditions and restrictions as may be required by Rule 16b-3 to qualify for the maximum exemption from Section 16
of the Exchange Act with respect to Plan transactions.

 

    12

     

    

 

27.            Indemnification.
No member of the Board or the Committee, nor any employee or agent of the Company exercising authority delegated by the Board or the Committee
hereunder (each such person, an “Indemnifiable Person”), shall be liable for any action taken or omitted to be taken
or any determination made in the administration of the Plan (unless constituting fraud or a willful criminal act or willful criminal omission).
Each Indemnifiable Person shall be indemnified and held harmless by the Company against and from any loss, cost, liability, or expense
(including attorneys’ fees) that may be imposed upon or incurred by such Indemnifiable Person in connection with or resulting from
any action, suit, or proceeding to which such Indemnifiable Person may be involved as a party or witness or otherwise by reason of any
action taken or omitted to be taken or determination made under the Plan and against and from any and all amounts paid by such Indemnifiable
Person with the Company’s approval (not to be unreasonably withheld) in settlement thereof, or paid by such Indemnifiable Person
in satisfaction of any judgment in any such action, suit, or proceeding against such Indemnifiable Person, and the Company shall advance
to such Indemnifiable Person any such expenses promptly upon written request (which request shall include an undertaking by the Indemnifiable
Person to repay the amount of such advance if it shall ultimately be determined as provided below that the Indemnifiable Person is not
entitled to be indemnified); provided, that the Company shall have the right, at its own expense, to assume and defend any such
action, suit, or proceeding, and once the Company gives notice of its intent to assume the defense, the Company shall have sole control
over such defense with counsel of recognized standing of the Company’s choice. The foregoing right of indemnification shall not
be available to an Indemnifiable Person to the extent that a final judgment or other final adjudication (in either case not subject to
further appeal) binding upon such Indemnifiable Person determines that the acts or omissions or determinations of such Indemnifiable Person
giving rise to the indemnification claim resulted from such Indemnifiable Person’s fraud or willful criminal act or willful criminal
omission or that such right of indemnification is otherwise prohibited by law or by the Company’s certificate of incorporation or
by-laws. The foregoing right of indemnification shall not be exclusive of or otherwise supersede any other rights of indemnification to
which such Indemnifiable Persons may be entitled under the Company’s certificate of incorporation or by-laws, as a matter of law,
individual indemnification agreement or contract or otherwise, or any other power that the Company may have to indemnify such Indemnifiable
Persons or hold them harmless.

 

28.            Nonexclusivity
of the Plan. Neither the adoption of the Plan by the Board nor the submission of the Plan to
the shareholders of the Company for approval shall be construed as creating any limitations on the power of the Board to adopt such other
incentive arrangements as it may deem desirable, including, without limitation, the granting of stock options or awards otherwise than
under the Plan, and such arrangements may be either applicable generally or only in specific cases.

 

    13

     

    

 

29.           No
Trust or Fund Created. The Plan shall not create or be construed to create a trust or separate
fund of any kind or a fiduciary relationship between the Company or any affiliate, on the one hand, and the Participant or other person
or entity, on the other hand. No provision of the Plan shall require the Company, for the purpose of satisfying any obligations under
the Plan, to purchase assets or place any assets in a trust or other entity to which contributions are made or to otherwise segregate
any assets, nor shall the Company maintain separate bank accounts, books, records, or other evidence of the existence of a segregated
or separately maintained or administered fund for such purposes. Participants shall have no rights under the Plan other than as unsecured
general creditors of the Company.

 

30.           Reliance
on Reports. Each member of the Committee and each member of the Board (and each such member’s
respective designees) shall be fully justified in acting or failing to act, as the case may be, and shall not be liable for having so
acted or failed to act in good faith, in reliance upon any report made by the independent registered public accounting firm of the Company
and its affiliates and/or any other information furnished in connection with the Plan by any agent of the Company or the Committee or
the Board, other than such member or designee.

 

31.           Relationship
to Other Benefits. No payment under the Plan shall be taken into account in determining any benefits
under any pension, retirement, profit sharing, group insurance, or other benefit plan of the Company except as otherwise specifically
provided in such other plan.

 

32.           Governing
Law. The Plan shall be governed by and construed in accordance with the laws of the State of
Delaware, without regard to principles of conflicts of laws thereof, or principles of conflicts of laws of any other jurisdiction that
could cause the application of the laws of any jurisdiction other than the State of Delaware.

 

33.           Severability.
If any provision of the Plan is or becomes or is deemed to be invalid, illegal, or unenforceable in any jurisdiction or as to any person
or entity, or would disqualify the Plan under any law deemed applicable by the Committee, such provision shall be construed or deemed
amended to conform to the applicable laws, or if it cannot be construed or deemed amended without, in the determination of the Committee,
materially altering the intent of the Plan, such provision shall be construed or deemed stricken as to such jurisdiction, person, or entity,
and the remainder of the Plan shall remain in full force and effect.

 

34.           Titles
and Headings. The titles and headings of the sections in the Plan are for convenience of reference
only, and in the event of any conflict, the text of the Plan, rather than such titles or headings shall control.

 

* * *

 

    14Exhibit 4.4

    

  

   

  

  
    

    

    

    

    WARRANT AGREEMENT

    between

    AxonPrime Infrastructure Acquisition Corporation

    and

    Computershare Inc.

    Computershare Trust Company, N.A.

    

    

    THIS WARRANT AGREEMENT (this “Agreement”), dated as of _____________, 2021, is by and between
      AxonPrime Infrastructure Acquisition Corporation, a Delaware corporation (the “Company”), Computershare Inc., a Delaware
      corporation and Computershare Trust Company, N.A., a federally chartered trust company, collectively, as warrant agent (the “Warrant Agent”, also referred to herein as the “Transfer Agent”).

    

    

    WHEREAS, the Company has entered into that certain Warrant Purchase Agreement with AxonPrime Infrastructure Sponsor LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor will purchase an aggregate of 3,333,333 warrants (or up to 3,633,333 warrants if the Over-allotment Option (as defined
      below) in connection with the Company’s Offering (as defined below) is exercised in full) simultaneously with the closing of the Offering bearing the legend set forth in Exhibit B hereto (the “Private Placement Warrants”) at a purchase price of $1.50 per Private Placement Warrant; and

    

    

    WHEREAS, the Company is engaged in an initial public offering (the “Offering”) of

      units of the Company’s equity securities, each such unit comprised of one share of Common Stock (as defined below) and one-third of one Public Warrant (as defined below) (the “Units”) and, in connection therewith, has determined to issue and deliver up to 5,750,000 warrants (including up to 750,000 warrants subject to the Over-allotment Option) to public investors in the
      Offering (the “Public Warrants” and, together with the Private Placement Warrants, the “Warrants”). Each whole Warrant entitles the holder thereof to purchase one share of Class A common stock of the Company, par value $0.0001 per share (“Common Stock”), for $11.50 per share, subject to adjustment as described herein; and

    

    

    WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) the registration statement on Form S-1, No. 333-257777 (the “Registration Statement’’) and prospectus (the “Prospectus”), for the registration, under the Securities Act of 1933, as amended (the “Securities Act”), of the sale of the Units, the Public Warrants and the Common Stock included in the Units; and

    

    

    WHEREAS, the Company desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance, registration, transfer, exchange,
      redemption and exercise of the Warrants; and

    

    

    WHEREAS, the Company desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective rights, limitation of rights, and
      immunities of the Company, the Warrant Agent, and the holders of the Warrants; and

    

    

    WHEREAS, all acts and things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned by or on behalf of the Warrant Agent, as
      provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

    

    

    NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

    

    

    1. Appointment of Warrant Agent. The Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such appointment and agrees to perform the
      same in accordance with the express terms and conditions set forth in this Agreement (and no implied terms and conditions).

    

    

    2. Warrants.

    

    

    2.1 Form of Warrant. Each Warrant shall be issued in registered form only.

    

    

    
      
        

    

    
    2.2 Effect of Countersignature. If a physical certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant shall be invalid and of no
      effect and may not be exercised by the holder thereof.

    

    

    2.3 Registration.

    

    

    2.3.1 Warrant Register. The Warrant Agent shall maintain books (the “Warrant Register”), for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in
      the names of the respective holders thereof in such denominations and otherwise in accordance with the written instructions delivered to the Warrant Agent by the Company. Ownership of beneficial interests in the Public Warrants shall be shown on, and
      the transfer of such ownership shall be effected through, records maintained by institutions that have accounts with the Depository Trust Company (the “Depositary”) (such institution, with respect to a Warrant in its account, a “Participant”).

    

    

    If the Depositary subsequently ceases to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making other
      arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the
      Depositary to deliver to the Warrant Agent for cancellation each book-entry Public Warrant, and the Company shall instruct the Warrant Agent to deliver to the Depositary definitive certificates in physical form evidencing such Warrants which shall be
      in the form annexed hereto as Exhibit A.

    

    

    Physical certificates, if issued, shall be signed by, or bear the facsimile signature of, the Chairman of the Board, Chief Executive Officer, Chief Financial Officer, Secretary or
      other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be
      issued with the same effect as if he or she had not ceased to be such at the date of issuance.

    

    

    2.3.2 Registered Holder. Prior to due presentment for registration of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name
      such Warrant is registered in the Warrant Register (the “Registered Holder”) as the absolute owner of such Warrant and of each
      Warrant represented thereby (notwithstanding any notation of ownership or other writing on any physical certificate made by anyone other than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and
      neither the Company nor the Warrant Agent shall be affected by any notice to the contrary.

    

    

    2.4 Detachability of Warrants. The Common Stock and Public Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day
      is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with

      the consent of Morgan Stanley & Co. LLC, on behalf of the underwriters, but in no event shall the Common Stock and the Public Warrants comprising the Units be separately traded until (A) the Company has filed a current report on Form 8-K with the
      Commission containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of their right to purchase additional
      Units in the Offering (the “Over-allotment Option”), if the Over-allotment Option is exercised prior to the filing of the Form
      8-K, and (B) the Company issues a press release and files with the Commission a current report on Form 8-K announcing when such separate trading shall begin.

    

    

    
      2

      
        

    

    2.5 No Fractional Warrants Other Than as Part of Units. The Company shall not issue fractional Warrants other than as part of Units, each of which is comprised of one share of Common Stock
      and one-third of one Public Warrant. If, upon the detachment of Public Warrants from Units or otherwise, a holder of Warrants would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of
      Warrants to be issued to such holder.

    

    

    2.6 Private Placement Warrants. The Private Placement Warrants shall be identical to the Public Warrants, except that so long as they are held by the Sponsor or any of its Permitted
      Transferees (as defined below) the Private Placement Warrants: (i) may be exercised for cash or on a cashless basis, pursuant to subsection 3.3.1(c) hereof, (ii) may not be transferred, assigned or sold until thirty (30) days after the
      completion by the Company of an initial Business Combination (as defined below), (iii) shall not be redeemable by the Company pursuant to Section 6.1.1 hereof and (iv) shall only be redeemable by the Company pursuant to Section 6.1.2 if the last
      sales price of the Common Stock reported is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof); provided, however, that in the case of (ii), the Private Placement Warrants and any shares of
      Common Stock held by the Sponsor or any of its Permitted Transferees and issued upon exercise of the Private Placement Warrants may be transferred by the holders thereof:

    

    

    (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the Sponsor, or any affiliates of the Sponsor;

    

    

    (b) in the case of an individual, by gift to a member of one of the members of the individual’s immediate family or to a trust, the beneficiary of which is a member of one of the individual’s
      immediate family, an affiliate of such person or to a charitable organization;

    

    

    (c) in the case of an individual, by virtue of the laws of descent and distribution upon death of the individual;

    

    

    (d) in the case of an individual, pursuant to a qualified domestic relations order;

    

    

    (e) by private sales or transfers made in connection with the consummation of the Company’s initial Business Combination at prices no greater than the price at which the Warrants were originally
      purchased;

    

    

    (f) in the event of the Company’s liquidation prior to the completion of the Company’s initial Business Combination; or

    

    

    (g) by virtue of the laws of Delaware or the Sponsor’s limited liability company agreement upon dissolution of the Sponsor; or

    

    

    (h) in the event of the Company’s liquidation, merger, capital stock exchange, reorganization or other similar transaction which results in all of the Company’s stockholders having the right to
      exchange their shares of Common Stock for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination;

    

    

    provided, however, that in the case of clauses (a) through (e), these permitted transferees (the “Permitted Transferees”) must enter into a written agreement agreeing to be bound by these transfer restrictions.

    

    

    3. Terms and Exercise of Warrants.

    

    

    3.1 Warrant Price. Each Warrant shall, when countersigned by the Warrant Agent, entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, to
      purchase from the Company the number of shares of Common Stock stated therein, at the price of $11.50 per share, subject to the adjustments provided in Section 4 hereof and in the last sentence of this Section 3.1. The term “Warrant
      Price” as used in this Agreement shall mean the price per share at which shares of Common Stock may be purchased at the time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration
      Date (as defined below) for a period of not less than twenty (20) Business Days, provided, that the Company shall provide at least three (3) Business Days prior written notice of such reduction to Registered Holders of the Warrants and, provided
      further that any such reduction shall be identical among all of the Warrants.

    

    

    
      3

      
        

    

    3.2 Duration of Warrants. A Warrant may be exercised only during the period (the “Exercise Period”) commencing on the later of: (i) the date that is thirty (30) days after the first date on which the Company completes a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar
      business combination, involving the Company and one or more businesses (a “Business Combination”), or (ii) the date that is twelve (12) months from the date of the closing of the Offering, and terminating at 5:00 p.m., New York City time on the earlier to occur of: (x) the date that is five (5) years after the date on which the
      Company completes its Business Combination, (y) the liquidation of the Company if the Company fails to complete a Business Combination, or (z) other than with respect to the Private Placement Warrants then held by the Sponsor or any Permitted
      Transferees with respect to a redemption pursuant to Section 6.1.1 hereof or, if the last sales price of the Common Stock reported has been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section
      6.1.2 hereof, the Redemption Date (as defined below) as provided in Section 6.2 hereof (the “Expiration Date”); provided,
      however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in subsection 3.3.2 below with respect to an effective registration statement. Except with respect to the right
      to receive the Redemption Price (as defined below) (other than with respect to a Private Placement Warrant then held by the Sponsor or any Permitted Transferees with respect to a redemption pursuant to Section 6.1.1 hereof or, if the last
      sales price of the Common Stock reported has been at least $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.1.2 hereof) in the event of a redemption (as set forth in Section 6 hereof), each
      Warrant (other than a Private Placement Warrant then held by the Sponsor or any Permitted Transferees with respect to a redemption pursuant to Section 6.1.1 hereof or, if the last sales price of the Common Stock reported has been at least
      $18.00 per share (subject to adjustment in compliance with Section 4 hereof), Section 6.1.2 hereof) not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect thereof under this
      Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may extend the duration of the Warrants by delaying the Expiration Date; provided, that the Company shall provide at least twenty
      (20) days prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall be identical in duration among all the Warrants. The Company shall promptly notify the Warrant Agent in
      writing of such extension.

    

    

    3.3 Exercise of Warrants.

    

    

    3.3.1 Payment. Subject to the provisions of the Warrant and this Agreement, a Warrant, when countersigned by the Warrant Agent, may be exercised by the Registered Holder
      thereof by surrendering it, at the office of the Warrant Agent designated for such purposes, or at the office of its successor as Warrant Agent, with the subscription form, as set forth in the Warrant, duly executed, and by paying in full the Warrant
      Price for each full share of Common Stock as to which the Warrant is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the shares of Common Stock and the issuance of such
      shares of Common Stock, as follows:

    

    

    (a) in lawful money of the United States, in good certified check or good bank draft payable to the Warrant Agent;

    

    

    (b) in the event of a redemption pursuant to Section 6 hereof in which the Company’s board of directors (the “Board”)

      has elected to require all holders of the Warrants to exercise such Warrants on a “cashless basis,” by surrendering the Warrants for that number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of
      shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value”, as defined in this subsection 3.3.1(b) by (y) the Fair Market Value. Solely for purposes of this subsection

        3.3.1(b), Section 6.1.2 and Section 6.3, the “Fair Market Value” shall mean the average last sale price of the Common Stock for the ten (10) trading days ending on the third trading day prior to the date on which the notice of
      redemption is sent to the holders of the Warrants, pursuant to Section 6 hereof;

    

    

    (c) with respect to any Private Placement Warrant, so long as such Private Placement Warrant is held by the Sponsor or a Permitted Transferee, by surrendering the Warrants for that
      number of shares of Common Stock equal to the quotient obtained by dividing (x) the product of the number of shares of Common Stock underlying the Warrants, multiplied by the difference between the Warrant Price and the “Fair Market Value”, as
      defined in this subsection 3.3.1(c), by (y) the Fair Market Value. Solely for purposes of this subsection 3.3.1(c), the “Fair Market Value” shall mean the average last sale price of the Common Stock for the ten (10) trading days
      ending on the third trading day prior to the date on which notice of exercise of the Warrant is sent to the Warrant Agent;

    

    

    (d) or as provided in Section 6.1.2 hereof with respect to a Make-Whole Exercise; or

    

    

    (e) as provided in Section 7.4 hereof.

    

    

    
      4

      
        

    

    3.3.2 Issuance of Shares of Common Stock on Exercise. As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant
      Price (if payment is pursuant to subsection 3.3.1(a)), the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate, as applicable, for the number of full shares of Common Stock to which he, she or it
      is entitled, registered in such name or names as may be directed by him, her or it, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as applicable, for the number of shares of Common Stock
      as to which such Warrant shall not have been exercised. Notwithstanding the foregoing, the Company shall not be obligated to deliver any shares of Common Stock pursuant to the exercise of a Warrant and shall have no obligation to settle such Warrant
      exercise unless a registration statement under the Securities Act with respect to the shares of Common Stock underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject to the Company’s satisfying its
      obligations under Section 7.4. No Warrant shall be exercisable and the Company shall not be obligated to issue shares of Common Stock upon exercise of a Warrant unless the Common Stock issuable upon such Warrant exercise has been registered,
      qualified or deemed to be exempt under the securities laws of the state of residence of the Registered Holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant,
      the holder of such Warrant shall not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless, in which case the purchaser of a Unit containing such Public Warrants shall have paid the full purchase price for the
      Unit solely for the shares of Common Stock underlying such Unit. The Company may require holders of Public Warrants to settle the Warrant on a “cashless basis” pursuant to Section 7.4. If, by reason of any exercise of Warrants on a “cashless
      basis”, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share of Common Stock, the Company shall round down to the nearest whole number, the number of shares of Common Stock to be
      issued to such holder.

    

    

    3.3.3 Valid Issuance. All shares of Common Stock issued upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and
      non-assessable.

    

    

    3.3.4 Date of Issuance. Each person in whose name any book-entry position or certificate, as applicable, for shares of Common Stock is issued shall for all purposes be
      deemed to have become the holder of record of such shares of Common Stock on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of
      delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall
      be deemed to have become the holder of such shares of Common Stock at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.

    

    

    3.3.5 Maximum Percentage. A holder of a Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this subsection
        3.3.5; however, no holder of a Warrant shall be subject to this subsection 3.3.5 unless he, she or it makes such election. If the election is made by a holder, the Warrant Agent shall not affect the exercise of the holder’s
      Warrant, and such holder shall not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the Warrant Agent’s actual knowledge (without further
      investigation or inquiry), would beneficially own in excess of 9.8% (the “Maximum Percentage”) of the shares of Common Stock
      outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such person and its affiliates shall include the number of shares of Common
      Stock issuable upon exercise of the Warrant with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant
      beneficially owned by such person and its affiliates and (y) exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and its affiliates (including, without limitation,
      any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph,
      beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of the Warrant, in determining the number of outstanding shares of Common Stock, the holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent annual report on
      Form 10-K, quarterly report on Form 10-Q, current report on Form 8-K or other public filing with the Commission as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent
      setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company shall, within two (2) Business Days, confirm orally and in writing to such holder the
      number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall be determined after giving effect to the conversion or exercise of equity securities of the Company by the holder and its
      affiliates since the date as of which such number of outstanding shares of Common Stock was reported. By written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to such
      holder to any other percentage specified in such notice; provided, however, that any such increase shall not be effective until the sixty-first (61st) day after such notice is delivered to the Company.

    

    

    
      5

      
        

    

    4. Adjustments.

    

    

    4.1 Stock Dividends.

    

    

    4.1.1 Split-Ups. If after the date hereof, and subject to the provisions of Section 4.6 below, the number of outstanding shares of Common Stock is increased by a
      stock dividend payable in shares of Common Stock, or by a split-up of shares of Common Stock or other similar event, then, on the effective date of such stock dividend, split-up or similar event, the number of shares of Common Stock issuable upon
      exercise of each Warrant shall be increased in proportion to such increase in the outstanding shares of Common Stock. A rights offering to holders of the Common Stock entitling holders to purchase shares of Common Stock at a price less than the “Fair
      Market Value” (as defined below) shall be deemed a stock dividend of a number of shares of Common Stock equal to the product of (i) the number of shares of Common Stock actually sold in such rights offering (or issuable under any other equity
      securities sold in such rights offering that are convertible into or exercisable for the Common Stock) multiplied by (ii) one (1) minus the quotient of (x) the price per share of Common Stock paid in such rights offering divided by (y) the Fair
      Market Value. For purposes of this subsection 4.1.1, (i) if the rights offering is for securities convertible into or exercisable for Common Stock, in determining the price payable for Common Stock, there shall be taken into account any
      consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) “Fair Market Value” means the volume weighted average price of the Common Stock as reported during the ten (10) trading day period
      ending on the trading day prior to the first date on which the shares of Common Stock trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

    

    

    4.1.2 Extraordinary Dividends. If the Company, at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities
      or other assets to the holders of the Common Stock on account of such shares of Common Stock (or other shares of the Company’s capital stock into which the Warrants are convertible), other than (a) as described in subsection 4.1.1 above, (b)
      Ordinary Cash Dividends (as defined below), (c) to satisfy the redemption rights of the holders of the Common Stock in connection with a proposed initial Business Combination, (d) to satisfy the redemption rights of the holders of Common Stock in
      connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with its initial Business Combination or
      to  redeem 100% of Common Stock if the Company does not complete the Business Combination within the time period set forth therein or (ii) with respect to any other provision relating to the Company’s stockholders’ rights or pre-initial Business
      Combination activity, or (e) in connection with the redemption of public shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution of its assets upon its liquidation (any such non-excluded
      event being referred to herein as an “Extraordinary Dividend’), then the Warrant Price
      shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each share of
      Common Stock in respect of such Extraordinary Dividend. For purposes of this subsection 4.1.2, “Ordinary Cash Dividends” means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash dividends and cash distributions paid on the Common Stock
      during the 365-day period ending on the date of declaration of such dividend or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this Section 4 and excluding cash dividends or cash
      distributions that resulted in an adjustment to the Warrant Price or to the number of shares of Common Stock issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the Offering).

    

    

    
      6

      
        

    

    4.2 Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 4.6 hereof, the number of outstanding shares of Common Stock is decreased by a
      consolidation, combination, reverse stock split or reclassification of shares of Common Stock or other similar event, then, on the effective date of such consolidation, combination, reverse stock split, reclassification or similar event, the number
      of shares of Common Stock issuable on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding shares of Common Stock.

    

    

    4.3 Adjustments in Exercise Price.

    

    

    4.3.1 Whenever the number of shares of Common Stock purchasable upon the exercise of the Warrants is adjusted, as provided in subsection 4.1.1 or Section 4.2 above,
      the Warrant Price shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the numerator of which shall be the number of shares of Common Stock purchasable upon the exercise of
      the Warrants immediately prior to such adjustment, and (y) the denominator of which shall be the number of shares of Common Stock so purchasable immediately thereafter.

    

    

    4.3.2 If (x) the Company issues additional shares of Common Stock or equity-linked securities for capital raising purposes in connection with the closing of its initial Business
      Combination at an issue price or effective issue price of less than $9.20 per share of Common Stock (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the Sponsor or
      its affiliates, without taking into account any shares of Class B common stock, par value $0.0001 per share, of the Company held by the Sponsor, certain executive officers of the Company, or such affiliates, as applicable, prior to such issuance)
      (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the Company’s initial Business Combination on the date of the
      completion of the Company’s initial Business Combination (net of redemptions), and (z) the volume-weighted average trading price of Common Stock during the twenty (20) trading day period starting on the trading day prior to the day on which the
      Company completes its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the
      newly issued price, and the $18.00 per share redemption trigger price will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the newly issued price.

    

    

    
      7

      
        

    

    4.4 Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding shares of Common Stock (other than a change under subsections
        4. 1.1 or 4.1.2 or Section 4.2 hereof or that solely affects the par value of such shares of Common Stock), or in the case of any merger or consolidation of the Company with or into another corporation (other than a
      consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the outstanding shares of Common Stock), or in the case of any sale or conveyance to another corporation
      or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the
      basis and upon the terms and conditions specified in the Warrants and in lieu of the shares of Common Stock of the Company immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of
      shares of stock or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the Warrants would have
      received if such holder had exercised his, her or its Warrant(s) immediately prior to such event (the “Alternative Issuance”); provided, however, that (i) if the holders of
      the Common Stock were entitled to exercise a right of election as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the
      Alternative Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per share by the holders of the Common Stock in such consolidation or merger that affirmatively make such
      election, and (ii) if a tender, exchange or redemption offer shall have been made to and accepted by the holders of the Common Stock (other than a tender, exchange or redemption offer made by the Company in connection with redemption rights held by
      stockholders of the Company as provided for in the Company’s amended and restated certificate of incorporation or as a result of the repurchase of shares of Common Stock by the Company if a proposed initial Business Combination is presented to the
      stockholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any
      successor rule)) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange Act (or any successor rule)) and any members of any such group of which any such affiliate
      or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 50% of the outstanding shares of Common Stock, the holder of a Warrant shall be entitled to receive as the
      Alternative Issuance, the highest amount of cash, securities or other property to which such holder would actually have been entitled as a stockholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange
      offer, accepted such offer and all of the Common Stock held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as
      possible to the adjustments provided for in this Section 4; provided, further, that if less than 70% of the consideration receivable by the holders of the Common Stock in the applicable event is payable in the form of common
      stock in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the Registered
      Holder properly exercises the Warrant within thirty (30) days following the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with the Commission, the Warrant Price shall be
      reduced by an amount (in dollars) equal to the difference of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) (but in no event less than zero) minus (B) the Black-Scholes Warrant
      Value (as defined below). The “Black-Scholes Warrant Value” means the value of a Warrant immediately prior to the consummation of
      the applicable event based on the Black-Scholes Warrant Model for a Capped American Call on Bloomberg Financial Markets (“Bloomberg”). For purposes of calculating such amount, (1) Section
        6 of this Agreement shall be taken into account, (2) the price of each share of Common Stock shall be the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to
      the effective date of the applicable event, (3) the assumed volatility shall be the 90-day volatility obtained from the HVT function on Bloomberg determined as of the trading day immediately prior to the day of the announcement of the applicable
      event, and (4) the assumed risk-free interest rate shall correspond to the U.S. Treasury rate for a period equal to the remaining term of the Warrant. “Per Share Consideration” means (i) if the consideration paid to holders of the Common Stock consists exclusively of cash, the amount of such cash per share of Common Stock, and (ii) in all other cases, the volume
      weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the effective date of the applicable event. If any reclassification or reorganization also results in a change in shares
      of Common Stock covered by subsection 4.1.1, then such adjustment shall be made pursuant to subsection 4.1.1 or Sections 4.2, 4.3 and this Section 4.4. The provisions of this Section 4.4 shall similarly
      apply to successive reclassifications, reorganizations, mergers or consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable upon exercise of the Warrant.

    

    

    4.5 Notices of Changes in Warrant. Upon every adjustment of the Warrant Price or the number of shares of Common Stock issuable upon exercise of a Warrant, the Company shall give written
      notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease, if any, in the number of shares of Common Stock purchasable at such price upon the exercise of a Warrant,
      setting forth in reasonable detail the method of calculation and the facts upon which such calculation is based. The Warrant Agent shall have no obligation under any section of this Agreement to determine whether any adjustment is required or to
      calculate any of the adjustments set forth herein. Upon the occurrence of any event specified in Sections 4.1, 4.2, 4.3 or 4.4, the Company shall give written notice of the occurrence of such event to each holder of a
      Warrant, at the last address set forth for such holder in the Warrant Register, and of the record date or the effective date of the event. Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.

    

    

    
      8

      
        

    

    4.6 No Fractional Shares. Notwithstanding any provision contained in this Agreement to the contrary, the Company shall not issue fractional shares of Common Stock upon the exercise of
      Warrants. If, by reason of any adjustment made pursuant to this Section 4, the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise,
      round down to the nearest whole number the number of shares of Common Stock to be issued to such holder.

    

    

    4.7 Form of Warrant. The form of Warrant need not be changed because of any adjustment pursuant to this Section 4, and Warrants issued after such adjustment may state the same Warrant
      Price and the same number of shares of Common Stock as is stated in the Warrants initially issued pursuant to this Agreement; provided, however, that the Company may at any time in its sole discretion make any change in the form of
      Warrant that the Company may deem appropriate and that does not affect the substance thereof or the rights, duties, obligations or immunities of the Warrant Agent, without the Warrant Agent’s prior written consent, and any Warrant thereafter issued
      or countersigned, whether in exchange or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.

    

    

    4.8 Other Events. In case any event shall occur affecting the Company as to which none of the provisions of preceding subsections of this Section 4 are strictly applicable, but which
      would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate the intent and purpose of this Section 4, then, in each such case, the Company shall appoint a firm of
      independent public accountants, investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment to the rights represented by the Warrants is necessary to effectuate the
      intent and purpose of this Section 4 and, if they determine that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is consistent with any adjustment recommended in
      such opinion.

    

    

    5. Transfer and Exchange of Warrants.

    

    

    5.1 Registration of Transfer. The Warrant Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant for
      transfer, properly endorsed with signatures properly guaranteed by an eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association and accompanied by appropriate instructions for
      transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and the old Warrant shall be cancelled by the Warrant Agent. The Warrants so cancelled shall be delivered by the Warrant Agent to the
      Company from time to time upon request.

    

    

    5.2 Procedure for Surrender of Warrants. Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant Agent shall
      issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered, representing an equal aggregate number of Warrants; provided, however, that in the event that a Warrant
      surrendered for transfer bears a restrictive legend (as in the case of the Private Placement Warrants), the Warrant Agent shall not cancel such Warrant and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of
      counsel for the Company stating that such transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.

    

    

    5.3 Fractional Warrants. The Warrant Agent shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate or book-entry
      position for a fraction of a warrant, except as part of the Units.

    

    

    5.4 Service Charges. No service charge shall be made for any exchange or registration of transfer of Warrants.

    

    

    5.5 Warrant Execution and Countersignature. The Warrant Agent is hereby authorized to countersign (in manual or facsimile form) and to deliver, in accordance with the terms of this Agreement,
      the Warrants required to be issued pursuant to the provisions of this Section 5, and the Company, whenever required by the Warrant Agent, shall supply the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.

    

    

    5.6 Transfer of Warrants. Prior to the Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and only for the
      purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the
      foregoing, the provisions of this Section 5.6 shall have no effect on any transfer of Warrants on and after the Detachment Date.

    

    

    
      9

      
        

    

    6. Redemption.

    

    

    6.1 Redemption of Warrants.

    

    

    6.1.1 Redemption when Price of Common Stock Equals or Exceeds $18.00. Subject to Sections 6.4 and 6.5 hereof, not less than all of the outstanding Public
      Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the Registered Holders of the Public Warrants, as described in Section

        6.2 below, at the price of $0.01 per Public Warrant (the “Redemption Price”), provided that the last sales price of the Common Stock reported has been at least $18.00 per share
      (subject to adjustment in compliance with Section 4 hereof), for any twenty (20) trading days within the thirty (30) trading-day period ending on the third trading day prior to the date on which notice of the redemption is given, even if
      there is no effective registration statement covering the shares of Common Stock issuable upon exercise of the Public Warrants available throughout the 30-day Redemption Period (as defined in Section 6.2 below).

    

    

    6.1.2 Redemption when Price of Common Stock Equals or Exceeds $10.00. Subject to Sections 6.4 and 6.5 hereof, not less than all of the outstanding Public
      Warrants may be redeemed, at the option of the Company, at any time while they are exercisable and prior to their expiration, at the office of the Warrant Agent, upon notice to the Registered Holders of the Public Warrants, as described in Section

        6.2 below, at a price of $0.10 per Public Warrant (the “Alternative Redemption Price”), provided that the Registered Holders of the Public Warrants may elect to exercise their Public
      Warrants on a “cashless basis” pursuant to subsection 3.3.1 and receive a number of shares of Common Stock determined by reference to the table below, based on the redemption date (calculated for purposes of the table as the period to
      expiration of the Warrants) and the “Fair Market Value” (as such term is defined in subsection 3.3.1(b)), provided further (i) that the last sales price of the Common Stock reported
      has been at least $10.00 per share (subject to adjustment in compliance with Section 4 hereof), on the trading day prior to the date on which notice of the redemption is given, (ii) there is an effective registration statement covering the
      Common Stock issuable upon exercise of the Public Warrants, and a current prospectus relating thereto, available throughout the 30-day Redemption Period (as defined in Section 6.2 below) and (iii) if the last sales price of the Common Stock
      reported is less than $18.00 per share (subject to adjustment in compliance with Section 4 hereof), the Private Placement Warrants are also concurrently called for redemption on the same terms as the outstanding Public Warrants.

     

    

    	 	 	 	
            Fair Market Value of Class A Common Stock

          
	
            Redemption Date (period

            to expiration of warrants)

          	 	 	
            <10.00

          	 	 	
            11.00

          	 	 	
            12.00

          	 	 	
            13.00

          	 	 	
            14.00

          	 	 	
            15.00

          	 	 	
            16.00

          	 	 	
            17.00

          	 	 	
            18.00

          
	
            60 months

          	 	 	
            0.261

          	 	 	
            0.281

          	 	 	
            0.297

          	 	 	
            0.311

          	 	 	
            0.324

          	 	 	
            0.337

          	 	 	
            0.348

          	 	 	
            0.358

          	 	 	
            0.361

          
	
            57 months

          	 	 	
            0.257

          	 	 	
            0.277

          	 	 	
            0.294

          	 	 	
            0.310

          	 	 	
            0.324

          	 	 	
            0.337

          	 	 	
            0.348

          	 	 	
            0.358

          	 	 	
            0.361

          
	
            54 months

          	 	 	
            0.252

          	 	 	
            0.272

          	 	 	
            0.291

          	 	 	
            0.307

          	 	 	
            0.322

          	 	 	
            0.335

          	 	 	
            0.347

          	 	 	
            0.357

          	 	 	
            0.361

          
	
            51 months

          	 	 	
            0.246

          	 	 	
            0.268

          	 	 	
            0.287

          	 	 	
            0.304

          	 	 	
            0.320

          	 	 	
            0.333

          	 	 	
            0.346

          	 	 	
            0.357

          	 	 	
            0.361

          
	
            48 months

          	 	 	
            0.241

          	 	 	
            0.263

          	 	 	
            0.283

          	 	 	
            0.301

          	 	 	
            0.317

          	 	 	
            0.332

          	 	 	
            0.344

          	 	 	
            0.356

          	 	 	
            0.361

          
	
            45 months

          	 	 	
            0.235

          	 	 	
            0.258

          	 	 	
            0.279

          	 	 	
            0.298

          	 	 	
            0.315

          	 	 	
            0.330

          	 	 	
            0.343

          	 	 	
            0.356

          	 	 	
            0.361

          
	
            42 months

          	 	 	
            0.228

          	 	 	
            0.252

          	 	 	
            0.274

          	 	 	
            0.294

          	 	 	
            0.312

          	 	 	
            0.328

          	 	 	
            0.342

          	 	 	
            0.355

          	 	 	
            0.361

          
	
            39 months

          	 	 	
            0.221

          	 	 	
            0.246

          	 	 	
            0.269

          	 	 	
            0.290

          	 	 	
            0.309

          	 	 	
            0.325

          	 	 	
            0.340

          	 	 	
            0.354

          	 	 	
            0.361

          
	
            36 months

          	 	 	
            0.213

          	 	 	
            0.239

          	 	 	
            0.263

          	 	 	
            0.285

          	 	 	
            0.305

          	 	 	
            0.323

          	 	 	
            0.339

          	 	 	
            0.353

          	 	 	
            0.361

          
	
            33 months

          	 	 	
            0.205

          	 	 	
            0.232

          	 	 	
            0.257

          	 	 	
            0.280

          	 	 	
            0.301

          	 	 	
            0.320

          	 	 	
            0.337

          	 	 	
            0.352

          	 	 	
            0.361

          
	
            30 months

          	 	 	
            0.196

          	 	 	
            0.224

          	 	 	
            0.250

          	 	 	
            0.274

          	 	 	
            0.297

          	 	 	
            0.316

          	 	 	
            0.335

          	 	 	
            0.351

          	 	 	
            0.361

          
	
            27 months

          	 	 	
            0.185

          	 	 	
            0.214

          	 	 	
            0.242

          	 	 	
            0.268

          	 	 	
            0.291

          	 	 	
            0.313

          	 	 	
            0.332

          	 	 	
            0.350

          	 	 	
            0.361

          
	
            24 months

          	 	 	
            0.173

          	 	 	
            0.204

          	 	 	
            0.233

          	 	 	
            0.260

          	 	 	
            0.285

          	 	 	
            0.308

          	 	 	
            0.329

          	 	 	
            0.348

          	 	 	
            0.361

          
	
            21 months

          	 	 	
            0.161

          	 	 	
            0.193

          	 	 	
            0.223

          	 	 	
            0.252

          	 	 	
            0.279

          	 	 	
            0.304

          	 	 	
            0.326

          	 	 	
            0.347

          	 	 	
            0.361

          
	
            18 months

          	 	 	
            0.146

          	 	 	
            0.179

          	 	 	
            0.211

          	 	 	
            0.242

          	 	 	
            0.271

          	 	 	
            0.298

          	 	 	
            0.322

          	 	 	
            0.345

          	 	 	
            0.361

          
	
            15 months

          	 	 	
            0.130

          	 	 	
            0.164

          	 	 	
            0.197

          	 	 	
            0.230

          	 	 	
            0.262

          	 	 	
            0.291

          	 	 	
            0.317

          	 	 	
            0.342

          	 	 	
            0.361

          
	
            12 months

          	 	 	
            0.111

          	 	 	
            0.146

          	 	 	
            0.181

          	 	 	
            0.216

          	 	 	
            0.250

          	 	 	
            0.282

          	 	 	
            0.312

          	 	 	
            0.339

          	 	 	
            0.361

          
	
            9 months

          	 	 	
            0.090

          	 	 	
            0.125

          	 	 	
            0.162

          	 	 	
            0.199

          	 	 	
            0.237

          	 	 	
            0.272

          	 	 	
            0.305

          	 	 	
            0.336

          	 	 	
            0.361

          
	
            6 months

          	 	 	
            0.065

          	 	 	
            0.099

          	 	 	
            0.137

          	 	 	
            0.178

          	 	 	
            0.219

          	 	 	
            0.259

          	 	 	
            0.296

          	 	 	
            0.331

          	 	 	
            0.361

          
	
            3 months

          	 	 	
            0.034

          	 	 	
            0.065

          	 	 	
            0.104

          	 	 	
            0.150

          	 	 	
            0.197

          	 	 	
            0.243

          	 	 	
            0.286

          	 	 	
            0.326

          	 	 	
            0.361

          
	
            0 months

          	 	 	
            —

          	 	 	
            —

          	 	 	
            0.042

          	 	 	
            0.115

          	 	 	
            0.179

          	 	 	
            0.233

          	 	 	
            0.281

          	 	 	
            0.323

          	 	 	
            0.361

          

     

    

    
      10

      
        

    

    The exact Fair Market Value and Redemption Date (as defined below) may not be set forth in the table above, in which case, if the Fair Market Value is between two values in the
      table or the Redemption Date is between two redemption dates in the table, the number of Common Stock to be issued for each Warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher
      and lower Fair Market Values and the earlier and later redemption dates, as applicable, based on a 365- or 366-day year, as applicable.

    

    

    The stock prices set forth in the column headings of the table above shall be adjusted as of any date on which the number of shares issuable upon exercise of a Warrant is adjusted
      pursuant to Section 4. The adjusted stock prices in the column headings shall equal the stock prices immediately prior to such adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a
      Warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a Warrant as so adjusted. The number of shares in the table above shall be adjusted in the same manner and at the same time
      as the number of shares issuable upon exercise of a Warrant. In no event will the number of shares issued in connection with a Make-Whole Exercise exceed 0.361 shares of Common Stock per Warrant (subject to adjustment).

    

    

    6.2 Date Fixed for, and Notice of, Redemption. In the event that the Company elects to redeem all of the Public Warrants pursuant to Section 6.1.1 or Section 6.1.2, the
      Company shall fix a date for the redemption (the “Redemption Date”). Notice of redemption shall be mailed by first class mail,
      postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (the “30-day Redemption Period”) to
      the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the
      Registered Holder received such notice.

    

    

    6.3 Exercise After Notice of Redemption. The Warrants may be exercised, for cash (or on a “cashless basis” in accordance with subsection 3.3.1(b) of this Agreement) at any time after
      notice of redemption shall have been given by the Company pursuant to Section 6.2 hereof and prior to the Redemption Date. In the event that the Company determines to require all holders of Public Warrants to exercise their Public Warrants on
      a “cashless basis” pursuant to subsection 3.3.1, the notice of redemption shall contain the information necessary to calculate the number of shares of Common Stock to be received upon exercise of the Public Warrants, including the “Fair
      Market Value” (as such term is defined in subsection 3.3.1(b) hereof) in such case. On and after the Redemption Date, the Registered Holders of the Public Warrants shall have no further rights except to receive, upon surrender of the Public
      Warrants, the Redemption Price or the Alterative Redemption Price, as applicable.

    

    

    6.4 Exclusion of Private Placement Warrants. The Company agrees that (a) the redemption rights provided in Section 6.1.1 shall not apply to the Private Placement Warrants if at the
      time of the redemption such Private Placement Warrants continue to be held by the Sponsor or its Permitted Transferees and (b) if the last sales price of the Common Stock reported has been at least $18.00 per share (subject to adjustment in
      compliance with Section 4 hereof), the redemption rights provided in Section 6.1.2 hereof shall not apply to the Private Placement Warrants if at the time of the redemption such Private Placement Warrants continue to be held by the Sponsor or
      its Permitted Transferees. However, once such Private Placement Warrants are transferred (other than to Permitted Transferees under Section 2.5), the Company may redeem the Private Placement Warrants pursuant to Section 6.1.1
      or Section 6.1.2 hereof, provided that the criteria for redemption are met, including the opportunity of the holder of such Private Placement Warrants to exercise the Private Placement Warrants prior to redemption pursuant to Section 6.3.
      Private Placement Warrants that are transferred to persons other than Permitted Transferees shall upon such transfer cease to be Private Placement Warrants and shall become Public Warrants under this Agreement.

    

    

    
      11

      
        

    

    6.5 Public Warrants held by the Company’s officers or directors. The Company agrees that if Public Warrants are held by any of the Company’s officers or directors, the Public Warrants held by
      such officers and directors will be subject to the redemption rights provided in Section 6.1.2, except that such officers and directors shall only receive “Fair Market Value” (“Fair
      Market Value” in this Section 6.5 shall mean the last sale price of the Public Warrants on the Redemption Date) for such Public Warrants if they exercise their Public Warrants in connection with such redemption.

    

    

    7. Other Provisions Relating to Rights of Holders of Warrants.

    

    

    7.1 No Rights as Stockholder. A Warrant does not entitle the Registered Holder thereof to any of the rights of a stockholder of the Company, including, without limitation, the right to
      receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as stockholders in respect of the meetings of stockholders or the election of directors of the Company or any other matter.

    

    

    7.2 Lost, Stolen, Mutilated, or Destroyed Warrants. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may issue a new Warrant of like denomination,
      tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed, upon receipt by Warrant Agent of an open penalty surety bond satisfactory to it and holding it and the Company harmless, absent notice to Warrant Agent that such certificates
      have been acquired by a bona fide purchaser, or on such terms as to indemnity satisfactory to each of them or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof). Any such
      new Warrant shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed Warrant shall be at any time enforceable by anyone.

    

    

    7.3 Reservation of Common Stock. The Company shall at all times reserve and keep available a number of its authorized but unissued shares of Common Stock that shall be sufficient to permit
      the exercise in full of all outstanding Warrants issued pursuant to this Agreement.

    

    

    7.4 Registration of Common Stock; Cashless Exercise at Company’s Option.

    

    

    7.4.1 Registration of the Common Stock. The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after the closing of its
      initial Business Combination, it shall use its commercially reasonable efforts to file with the Commission a registration statement for the registration, under the Securities Act, of the shares of Common Stock issuable upon exercise of the Warrants.
      The Company shall use its commercially reasonable efforts to cause the same to become effective within sixty (60) business days following its initial Business Combination and to maintain the effectiveness of such registration statement, and a current
      prospectus relating thereto, until the expiration of the Warrants in accordance with the provisions of this Agreement. If any such registration statement has not been declared effective by the 60th Business Day following the closing of the Business
      Combination, holders of the Warrants shall have the right, during the period beginning on the 61st Business Day after the closing of the Business Combination and ending upon such registration statement being declared effective by the Commission, and
      during any other period when the Company shall fail to have maintained an effective registration statement covering the shares of Common Stock issuable upon exercise of the Warrants, to exercise such Warrants on a “cashless basis,” by exchanging the
      Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number of shares of Common Stock equal to the lesser of (A) the quotient obtained by dividing (x) the product of the number of
      shares of Common Stock underlying the Warrants, multiplied by the excess of the “Fair Market Value” (as defined below) over the Warrant Price by (y) the Fair Market Value and (B) 0.361 shares of Common Stock per Warrant. Solely for purposes of this subsection

        7.4.1, “Fair Market Value” shall mean the volume weighted average price of the Common Stock as reported during the ten (10) trading day period ending on the trading day prior to the date that notice of exercise is received by the Warrant Agent
      from the holder of such Warrants or its securities broker or intermediary. The date that notice of cashless exercise is received by the Warrant Agent shall be conclusively determined by the Warrant Agent. In connection with the “cashless exercise” of
      a Public Warrant, the Company shall, upon request, provide the Warrant Agent with an opinion of counsel for the Company (which shall be an outside law firm satisfactory to the Warrant Agent with securities law experience) stating that (i) the
      exercise of the Warrants on a cashless basis in accordance with this subsection 7.4.1 is not required to be registered under the Securities Act and (ii) the shares of Common Stock issued upon such exercise shall be freely tradable under
      United States federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except
      as provided in subsection 7.4.2, for the avoidance of any doubt, unless and until all of the Warrants have been exercised, the Company shall continue to be obligated to comply with its registration obligations under the first three sentences
      of this subsection 7.4.1.

    

    

    
      12

      
        

    

    7.4.2 Cashless Exercise at Company’s Option. If the Common Stock is at the time of any exercise of a Warrant not listed on a national securities exchange such that it
      satisfies the definition of a “covered security” under Section 18(b)(1) of the Securities Act (or any successor rule), the Company may, at its option, (i) require holders of Public Warrants who exercise Public Warrants to exercise such Public
      Warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as described in subsection 7.4.1 and (ii) in the event the Company so elects, the Company shall (x) not be required to file or
      maintain in effect a registration statement for the registration, under the Securities Act, of the Common Stock issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to the contrary, and (y) use its commercially
      reasonable efforts to register the Common Stock issuable upon exercise of the Public Warrant under the blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption is not available.

    

    

    8. Concerning the Warrant Agent and Other Matters.

    

    

    8.1 Payment of Taxes. The Company shall from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance or delivery
      of shares of Common Stock upon the exercise of the Warrants, but the Company and the Warrant Agent shall not be obligated to pay any transfer taxes in respect of the Warrants or such shares of Common Stock. The Warrant Agent shall not have any duty
      or obligation to take any action under any section of this Agreement that requires the payment of taxes and/or charges unless and until it is satisfied that all such payments have been made.

    

    

    8.2 Resignation, Consolidation, or Merger of Warrant Agent.

    

    

    8.2.1 Appointment of Successor Warrant Agent. The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties
      and liabilities hereunder after giving thirty (30) days’ notice in writing to the Company. If the office of the Warrant Agent becomes vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant
      Agent in place of the Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant
      (who shall, with such notice, submit his Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for the County of New York for the appointment of a successor Warrant Agent at the
      Company’s cost. Any successor Warrant Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and having its principal office in the Borough of
      Manhattan, City and State of New York, and authorized under the laws of the United States to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any successor Warrant Agent shall
      be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason it
      becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant
      Agent hereunder; and upon request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor Warrant Agent all
      such authority, powers, rights, immunities, duties, and obligations.

    

    

    
      13

      
        

    

    8.2.2 Notice of Successor Warrant Agent. In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent
      and the Transfer Agent for the Common Stock not later than the effective date of any such appointment.

    

    

    8.2.3 Merger or Consolidation of Warrant Agent. Any corporation or other entity into which the Warrant Agent may be merged or with which it may be consolidated or any
      corporation or other entity resulting from any merger or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further act.

    

    

    8.3 Fees and Expenses of Warrant Agent.

    

    

    8.3.1 Remuneration. The Company agrees to pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder in accordance with a fee schedule
      to be mutually agreed upon and shall, pursuant to its obligations under this Agreement, reimburse the Warrant Agent upon demand for all of its reasonable expenses and counsel fees and other disbursements incurred in the preparation, delivery,
      negotiation, amendment, administration and execution of this Agreement and the exercise and performance of its duties hereunder.

    

    

    8.3.2 Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further
      and other acts, instruments, and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.

    

    

    8.4 Liability of Warrant Agent.

    

    

    8.4.1 Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or
      matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established
      by a statement signed by the Chief Executive Officer, Chief Financial Officer, Secretary or Chairman of the Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement and shall not be liable for any action
      taken or suffered in the absence of bad faith by it pursuant to the provisions of this Agreement.

    

    

    8.4.2 Indemnity. The Warrant Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad faith (in each case, as determined by a final,
      non-appealable judgment of a court of competent jurisdiction). The Company agrees to indemnify the Warrant Agent and save it harmless against any and all losses, liability, damage, judgment, fine, penalty, claim, demand, settlement, cost or expense,
      including costs and reasonable counsel fees, for anything done or omitted by the Warrant Agent in the execution, administration and performance of this Agreement, except as a result of the Warrant Agent’s gross negligence, willful misconduct or bad
      faith (in each case as determined by a final non-appealable judgment of a court of competent jurisdiction). Notwithstanding anything in this Agreement to the contrary, any liability of the Warrant Agent under this Agreement will be limited to the
      amount of annual fees paid by the Company to the Warrant Agent during the twelve (12) months immediately preceding the event for which recovery from the Warrant Agent is being sought. Anything to the contrary notwithstanding, in no event will the
      Warrant Agent be liable for special, punitive, indirect, incidental or consequential loss or damages of any kind whatsoever (including, without limitation, lost profits), even if the Warrant Agent has been advised of the likelihood of such loss or
      damages, and regardless of the form of action.

    

    

    
      14

      
        

    

    8.4.3 Exclusions. The Warrant Agent shall have no responsibility with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant
      (except its countersignature thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Warrant. The Warrant Agent shall not be responsible to make any
      adjustments required under the provisions of Section 4 hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would require any such adjustment; nor shall it by any
      act hereunder be deemed to make any representation or warranty as to the authorization or reservation of any shares of Common Stock to be issued pursuant to this Agreement or any Warrant or as to whether any shares of Common Stock shall, when issued,
      be valid and fully paid and non-assessable. The Warrant Agent shall have no duty or obligation to investigate or confirm whether the Company’s determination of the number of shares to be issued on the exercise of Warrants, pursuant to Section 3.3, is
      accurate or correct.  Further, in the event of a cash exercise, the Company shall instruct the Warrant Agent to record the cost basis for the newly issued shares and in the event of a cashless exercise the Company shall provide the cost basis for the
      shares issued pursuant to a cashless exercise at the time the Company provides the cashless exercise ratio to the Warrant Agent.

    

    

    8.5 Acceptance of Agency. The Warrant Agent hereby accepts the agency established by this Agreement and agrees to perform the same upon the express terms and conditions herein set forth and
      shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company, all monies received by the Warrant Agent for the purchase of shares of Common Stock through the exercise of the Warrants.

    

    

    8.6 Other Rights and Duties of the Warrant Agent.

    

    

    8.6.1 Legal Counsel. The Warrant Agent may consult with legal counsel selected by it (who may be legal counsel for the Company or an employee or legal counsel of the
      Warrant Agent), and the advice or opinion of such counsel shall be full and complete authorization and protection to the Warrant Agent and the Warrant Agent shall incur no liability for or in respect of any action taken, suffered or omitted to be
      taken by it and in accordance with such advice or opinion.

    

    

    8.6.2 No Risk of Own Funds. No provision of this Agreement shall require the Warrant Agent to expend or risk its own funds or otherwise incur any financial liability in the
      performance of any of its duties hereunder or in the exercise any of its rights or powers if it believes that repayment of such funds or adequate indemnification against such risk or liability is not reasonably assured to it.

    

    

    8.6.3 No Interest. The Warrant Agent shall have no responsibility to the Company, any holders of Warrants or any other person for interest or earnings on any moneys held by
      the Warrant Agent pursuant to this Agreement.

    

    

    8.6.4 No Notice. The Warrant Agent shall not be required to take notice or be deemed to have notice of any event or condition hereunder, including any event or condition
      that may require action by the Warrant Agent, unless the Warrant Agent shall be specifically notified in writing of such event or condition by the Company, and all notices or other instruments required by this Agreement to be delivered to the Warrant
      Agent must, in order to be effective, be received by the Warrant Agent as specified in Section 9.2 hereof, and in the absence of such notice so delivered, the Warrant Agent may conclusively assume no such event or condition exists. The
      Warrant Agent shall be fully protected in relying on any such notice and shall have no duty or liability (in the absence of bad faith by it) with respect to, and shall not be deemed to have knowledge of any such event unless and until it shall have
      received such notice.

    

    

    8.6.5 Opinion of Counsel. The Company shall provide an opinion of counsel reasonably satisfactory to the Warrant Agent prior to the effective date of this Agreement to set
      up a reserve of Warrants and related shares of Common Stock. The opinion shall state that all Warrants, as applicable, are: (1) registered under the Securities Act or are exempt from such registration; and (2) validly issued, fully paid and
      non-assessable.

    

    

    8.6.6 Survival. The obligations of the Company and the rights and immunities of the Warrant Agent contained in this Section 8 shall survive the expiration of the Warrants
      and the termination of this Agreement and the resignation, replacement or removal of the Warrant Agent.

    

    

    
      15

      
        

    

    8.7 Waiver. The Warrant Agent has no right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to
      any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek recourse,
      reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby waives any and all Claims against the Trust Account and any and all rights to seek access to the Trust Account.

    

    

    8.8. Bank Accounts; Delivery of Exercise Price. All funds received by Computershare under this Agreement that are to be distributed or applied by Computershare in the performance of services
      (the “Funds”) shall be held by Computershare as agent for the Company and deposited in one or more bank accounts to be maintained by Computershare in its name as agent for the Company. 
      Until paid pursuant to the terms of this Agreement, Computershare will hold the Funds through such accounts in: deposit accounts of commercial banks with Tier 1 capital exceeding $1 billion or with an average rating above investment grade by S&P
      (LT Local Issuer Credit Rating), Moody’s (Long Term Rating) and Fitch Ratings, Inc. (LT Issuer Default Rating) (each as reported by Bloomberg Finance L.P.).  Computershare shall have no responsibility or liability for any diminution of the Funds that
      may result from any deposit made by Computershare in accordance with this paragraph, including any losses resulting from a default by any bank, financial institution or other third party.  Computershare may from time to time receive interest,
      dividends or other earnings in connection with such deposits.  Computershare shall not be obligated to pay such interest, dividends or earnings to the Company, any holder or any other party. The Warrant Agent shall forward funds received for warrant
      exercises in a given month by the 5th business day of the following month by wire transfer to an account designated by the Company.

    

    

    9. Miscellaneous Provisions.

    

    

    9.1 Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective successors
      and assigns.

    

    

    9.2 Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently
      given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company
      with the Warrant Agent), as follows:

    

    

    AxonPrime Infrastructure Acquisition Corporation

    126 E 56th St., 30th Floor

    New York, New York 10022

    Attention: Jon Layman

    

    

    with a copy (which shall not constitute notice) to:

    

    

    Hogan Lovells US LLP

    390 Madison Ave.

    New York, New York 10017

    Attention: Richard Aftanas

    

    

    Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given when in writing
      and so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent
      with the Company), as follows:

    

    

    Computershare Inc.

    Computershare Trust Company, N.A.

    150 Royall Street

    Canton, MA 02021

    Attention: Client Services

    

    

    
      16

      
        

    

    9.3 Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New
      York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in
      any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be
      exclusive. Subject to applicable law, the Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to (i)
      suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum or (ii) any of the types of actions that are required
      to be brought in the Court of Chancery in the State of Delaware pursuant to the Company’s amended and restated certificate of incorporation (as the same may be further amended or amended and restated from time to time).

    

    

    Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this Section 9.3. If any action,
      the subject matter of which is within the scope of the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a “foreign action”)
      in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern
      District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon
      such warrant holder’s counsel in the foreign action as agent for such warrant holder.

    

    

    9.4 Persons Having Rights under this Agreement. Nothing in this Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto and the
      Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained
      in this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered Holders of the Warrants.

    

    

    9.5 Examination of the Warrant Agreement. A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent designated for such purposes, for inspection
      by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to submit his Warrant for inspection by it.

    

    

    9.6 Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all
      such counterparts shall together constitute but one and the same instrument.

    

    

    9.7 Effect of Headings. The section headings herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.

    

    

    9.8 Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the purpose of curing any ambiguity, or curing, correcting or
      supplementing any defective provision contained herein, including to conform the provisions of this Agreement to the description of the terms of this Agreement set forth in the prospectus included in the Company’s Form S-1 filed with the U.S.
      Securities and Exchange Commission, or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not adversely affect the
      interest of the Registered Holders. All other modifications or amendments, including any amendment to increase the Warrant Price or shorten the Exercise Period and any amendment to the terms of only the Private Placement Warrants, shall require the
      vote or written consent of the Registered Holders of 50% of the then outstanding Public Warrants. Notwithstanding the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to Sections 3.1
      and 3.2, respectively, without the consent of the Registered Holders. As a condition precedent to the Warrant Agent’s execution of any amendment, an appropriate officer of the Company shall deliver a certificate which states that the proposed
      amendment is in compliance with the terms of this Section 9.8. No amendment to this Agreement shall be effective unless duly executed by the Warrant Agent.

    

    

    
      17

      
        

    

    9.9 Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this
      Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such
      invalid or unenforceable provision as may be possible and be valid and enforceable; provided, however, that if such excluded provision shall adversely affect the rights, immunities, liabilities, duties or obligations of the Warrant Agent, the Warrant
      Agent shall be entitled to resign immediately upon written notice to the Company.

    

    

    9.10. Force Majeure. Notwithstanding anything to the contrary contained herein, the Warrant Agent will not be liable for any delays or failures in performance resulting from acts beyond its
      reasonable control including, without limitation, acts of God, terrorist acts, shortage of supply, breakdowns or malfunctions, interruptions or malfunction of computer facilities, or loss of data due to power failures or mechanical difficulties with
      information storage or retrieval systems, labor difficulties, war, or civil unrest.

    

    

    Exhibit A – Form of Warrant Certificate

    

    

    Exhibit B – Private Placement Warrants Legend

    

    

    [Signature Page Follows]

    

    

    

    

    
      18

      
        

    

    IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the date first above written.

     

    

    
      	
               

            	
              AXONPRIME INFRASTRUCTURE

               ACQUISITION CORPORATION

            
	
               

            	
               

            	
               

            
	
               

            	By:

            	
               

            
	
               

            	
               

            	Name:

            
	
               

            	
               

            	
              Title: 

              

            
	
               

            	
               

            	
               

            
	
               

            	
              COMPUTERSHARE INC.

              

              COMPUTERSHARE TRUST COMPANY, N.A.

              

              as Warrant Agent

              

            
	
               

            	
               

            	
               

            
	
               

            	
              By: 

              

            	
               

            
	
               

            	
               

            	
              Name: 

              

            
	
               

            	
               

            	Title:

            
	
               

            	
               

            	
               

            

       

      

    

    

    

    
      
        

    

    EXHIBIT A

    

    

    Form of Warrant Certificate

    

    

    [FACE]

    

    

    Number

    

    

    Warrants

    

    

    THIS WARRANT SHALL BE VOID IF NOT EXERCISED PRIOR TO

    THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR

    IN THE WARRANT AGREEMENT DESCRIBED BELOW

     

    

    AXONPRIME INFRASTRUCTURE ACQUISITION CORPORATION

    Incorporated Under the Laws of the State of Delaware

    

    

    CUSIP 05467C 116

    

    

    Warrant Certificate

    

    

    This Warrant Certificate certifies that [•], or registered assigns, is the registered holder of warrant(s) evidenced hereby (the “Warrants” and each, a “Warrant”) to purchase shares of Class A common stock, $0.0001 par value (“Common Stock”), of AxonPrime Infrastructure Acquisition Corporation, a Delaware corporation (the “Company”). Each Warrant entitles the holder, upon exercise
      during the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable shares of Common Stock as set forth below, at the exercise price (the “Exercise Price”) as determined pursuant to the Warrant Agreement, payable in lawful money (or through “cashless exercise” as provided for in the Warrant
      Agreement) of the United States of America upon surrender of this Warrant Certificate and payment of the Exercise Price at the office or agency of the Warrant Agent referred to below, subject to the conditions set forth herein and in the Warrant
      Agreement. Defined terms used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

    

    

    Each Warrant is initially exercisable for one fully paid and non-assessable share of Common Stock. The number of shares of Common Stock issuable upon exercise of the Warrants is subject to adjustment
      upon the occurrence of certain events set forth in the Warrant Agreement.

    

    

    The initial Exercise Price per share of Common Stock for any Warrant is equal to $11.50 per share. The Exercise Price is subject to adjustment upon the occurrence of certain events set forth in the
      Warrant Agreement.

    

    

    Subject to the conditions set forth in the Warrant Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period, such
      Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement.

    

    

    Reference is hereby made to the further provisions of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as though fully
      set forth at this place.

    

    

    This Warrant Certificate shall not be valid unless countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.

    

    

    This Warrant Certificate shall be governed by and construed in accordance with the internal laws of the State of New York, without regard to conflicts of laws principles thereof.

    

    

    
      
        

    

    	 	 	 
	 	
            AXONPRIME INFRASTRUCTURE 

            ACQUISITION CORPORATION

          
	 	 	 
	 	
            By:

          	 
	 	 	
            Name:

          
	 	 	
            Title:

          
	 	 	 
	 	 	 
	 	 	 
	 	
            COMPUTERSHARE INC.

            COMPUTERSHARE TRUST COMPANY, N.A.,

             as Warrant Agent

          
	 	 	 
	 	
            By:

          	 
	 	 	
            Name:

          
	 	 	
            Title:

          

    

    

    

    

    
      
        

    

    Form of Warrant Certificate

    

    

    [Reverse]

    

    

    The Warrants evidenced by this Warrant Certificate are part of a duly authorized issue of Warrants entitling the holder on exercise to receive [•] shares of Common Stock and are issued or to be
      issued pursuant to a Warrant Agreement dated as of [•], 2021 (the “Warrant Agreement”), duly executed and delivered by the Company to Computershare Inc. and Computershare Trust Company,
      N.A., as warrant agent (the “Warrant Agent”), which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description of
      the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the words “holders” or “holder” meaning the Registered Holders or Registered Holder) of the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms used in this Warrant
      Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.

    

    

    Warrants may be exercised at any time during the Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by surrendering
      this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together with payment of the Exercise Price as specified in the Warrant Agreement (or through “cashless exercise” as provided for in the
      Warrant Agreement) at the office of the Warrant Agent designated for such purposes. In the event that upon any exercise of Warrants evidenced hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby,
      there shall be issued to the holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.

    

    

    Notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering the shares of
      Common Stock to be issued upon exercise is effective under the Securities Act and (ii) a prospectus thereunder relating to the shares of Common Stock is current, except through “cashless exercise” as provided for in the Warrant Agreement.

    

    

    The Warrant Agreement provides that upon the occurrence of certain events the number of shares of Common Stock issuable upon exercise of the Warrants set forth on the face hereof may, subject to
      certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest in a share of Common Stock, the Company shall, upon exercise, round down to the nearest whole number of shares of
      Common Stock to be issued to the holder of the Warrant.

    

    

    Warrant Certificates, when surrendered at the office of the Warrant Agent designated for such purpose by the Registered Holder thereof in person or by legal representative or attorney duly authorized
      in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate
      a like number of Warrants.

    

    

    Upon due presentation for registration of transfer of this Warrant Certificate at the office of the Warrant Agent a new Warrant Certificate or Warrant Certificates of like tenor and evidencing in the
      aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in
      connection therewith.

    

    

    The Company and the Warrant Agent may deem and treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership or other writing
      hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the
      Warrants nor this Warrant Certificate entitles any holder hereof to any rights of a stockholder of the Company.

    

    

    
      
        

    

    Election to Purchase

    

    

    (To Be Executed Upon Exercise of Warrant)

    

    

    The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant Certificate, to receive [•] shares of Common Stock and herewith tenders payment for such shares of Common
      Stock to the order of AxonPrime Infrastructure Acquisition Corporation (the “Company”) in the amount of $[•] in accordance with the terms hereof. The undersigned requests that a certificate for such shares of Common Stock be registered in the name of
      [•], whose address is [•] and that such shares of Common Stock be delivered to whose address is [•]. If said number of shares of Common Stock is less than all of the shares of Common Stock purchasable hereunder, the undersigned requests that a new
      Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of [•], whose address is [•] and that such Warrant Certificate be delivered to [•], whose address is [•].

    

    

    In the event that the Warrant has been called for redemption by the Company pursuant to Section 6 of the Warrant Agreement and the Company has required cashless exercise pursuant to Section

        6.3 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(b) and Section 6.3 of the Warrant Agreement.

    

    

    In the event that the Warrant is a Private Placement Warrant that is to be exercised on a “cashless” basis pursuant to subsection 3.3.1(c) of the Warrant Agreement, the number of shares of
      Common Stock that this Warrant is exercisable for shall be determined in accordance with subsection 3.3.1(c) of the Warrant Agreement.

    

    

    In the event that the Warrant is to be exercised on a “cashless” basis pursuant to Section 7.4 of the Warrant Agreement, the number of shares of Common Stock that this Warrant is exercisable
      for shall be determined in accordance with Section 7.4 of the Warrant Agreement.

    

    

    In the event that the Warrant may be exercised, to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of shares of Common Stock that this Warrant is exercisable for
      would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii) the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right,
      represented by this Warrant Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive shares of Common Stock. If said number of shares is less than all of the shares of Common Stock purchasable hereunder (after giving
      effect to the cashless exercise), the undersigned requests that a new Warrant Certificate representing the remaining balance of such shares of Common Stock be registered in the name of [•], whose address is [•] and that such Warrant Certificate be
      delivered to [•], whose address is [•].

    

    

    

    

    [Signature Page Follows]

     

    

     

    

    
      
        

    

    	 	 	 
	
            Date: __________, 2021

          	 	 
	 	 	
            (Signature)

          
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	
            (Address)

          
	 	 	 
	 	 	
            (Tax Identification Number)

          

     

    

    Signature Guaranteed:

    

    

    THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
      MEDALLION PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15 (OR ANY SUCCESSOR RULE)).

    

    

    
      
        

    

    EXHIBIT B

    

    

    LEGEND

    

    

    “THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED OR
      OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN
      THE LETTER AGREEMENT BY AND AMONG AXONPRIME INFRASTRUCTURE ACQUISITION CORPORATION (THE “COMPANY”), AXONPRIME INFRASTRUCTURE SPONSOR LLC AND THE OTHER PARTIES THERETO, THE SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED
      PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED TRANSFEREE (AS DEFINED IN SECTION
      2 OF THE WARRANT AGREEMENT) WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.

    

    

    SECURITIES EVIDENCED BY THIS CERTIFICATE AND SHARES OF CLASS A COMMON STOCK OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS
      AGREEMENT TO BE EXECUTED BY THE COMPANY.”

    

    

    No. Warrants [•]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00330-of-00352.parquet"}]]